Radiuspharm
Founded 2003 · 226 employees on LinkedIn · 1 known investors
Radius is a biopharmaceutical company focused on bone health and related therapeutic areas for underserved patient populations. It markets commercial products in the U.S., including TYMLOS (abaloparatide) injection and BINOSTO (alendronate sodium).
Investors · 1
Frequently asked questions
- What does Radiuspharm do?
- Radius is a biopharmaceutical company focused on bone health and related therapeutic areas for underserved patient populations. It markets commercial products in the U.S., including TYMLOS (abaloparatide) injection and BINOSTO (alendronate sodium).
- Who are Radiuspharm's investors?
- Radiuspharm's investors include OrbiMed.